Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
Ashkenazi
J
J
Sherman Fertility Institute, Golda Meir Medical Center, Petah-Tikva, Israel.
Goldman
J A
JA
Dicker
D
D
Feldberg
D
D
Goldman
G A
GA
D000328:Adult; D002064:Buserelin / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008186:Luteolytic Agents / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D010062:Ovulation Induction; D017329:Triptorelin Pamoate
D008186:Luteolytic Agents; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D002064:Buserelin